ChemoMetec A/S (CPH:CHEMM)

Market Cap	9.43B
Revenue (ttm)	459.54M
Net Income (ttm)	169.08M
Shares Out	17.40M
EPS (ttm)	9.72
PE Ratio	55.76
Forward PE	43.79
Dividend	4.00 (0.74%)
Ex-Dividend Date	Oct 11, 2024

Volume	25,501
Average Volume	24,965
Open	543.00
Previous Close	542.00
Day's Range	533.00 - 546.00
52-Week Range	339.00 - 616.00
Beta	1.53
RSI	58.53
Earnings Date	Sep 11, 2025

About ChemoMetec

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 174
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: CHEMM

Financial Performance

In 2024, ChemoMetec's revenue was 407.87 million, a decrease of -8.22% compared to the previous year's 444.40 million. Earnings were 136.28 million, a decrease of -23.72%.